NCT05048732View on ClinicalTrials.gov

Imaging Apoptosis for Lymphoma Treatment Response

EARLY_PHASE1TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 6, 2021

Primary Completion Date

February 10, 2024

Study Completion Date

February 10, 2024

Conditions
Diffuse Large B Cell Lymphoma
Interventions
DRUG

18F-FluorApoTrace

-The dose of 18F-FluorApoTrace to be given is 5 mCi

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

Washington University School of Medicine

OTHER